Every year the FTC brings hundreds of cases against individuals and companies for violating consumer protection and competition laws that the agency enforces. These cases can involve fraud, scams, identity theft, false advertising, privacy violations, anti-competitive behavior and more. The Legal Library has detailed information about cases we have brought in federal court or through our internal administrative process, called an adjudicative proceeding.
Capital City Mortgage Corporation, A Maryland Corporation; et. al
American Merchant Technologies, Inc., a Florida Corporation, et al., US v.
Empagran, S.A., et al., Plaintiffs-Appellants, v. F. Hoffmann-Laroche, Ltd., et al.
Genzyme Corporation and Ilex Oncology, Inc., In the Matter of
A consent order allowed Genzyme’s acquisition of ILEX Oncology, Inc., but requires the companies to divest certain assets in the market for solid organ transplant acute therapy drugs. Specifically, Genzyme is required to divest all contractual rights related to ILEX’s Campath®, an immunosuppressant antibody used in solid organ transplants to Schering AG.
Sobonito Investments Ltd, Defendant
Pereira, Carlos; d/b/a atariz.com, PremiaNet Corp, Atari Corp, and piratelynx.com; et al.
Enforma Natural Products, Inc., et al.
General Electric Company, In the Matter of
General Electric was permitted to acquire InVision Technologies, Inc. with conditions that it divest InVision's YXLON x-ray nondestructive testing and inspection equipment to a Commission approved acquirer. According to the complaint issued with the consent order, the two firms are direct competitors in a highly concentrated market. The consent order protects competition in the United States market for specialized x-ray testing and inspection including standard x-ray cabinets; x-ray systems equipped with automated defect recognition software; and high-energy x-ray generators.